Compare PYPD & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PYPD | UGRO |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.2M | 3.0M |
| IPO Year | 2020 | N/A |
| Metric | PYPD | UGRO |
|---|---|---|
| Price | $3.95 | $0.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $12.00 | $3.00 |
| AVG Volume (30 Days) | 87.0K | ★ 3.0M |
| Earning Date | 11-12-2025 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $59,985,138.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $28.40 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.30 | $0.21 |
| 52 Week High | $4.07 | $1.26 |
| Indicator | PYPD | UGRO |
|---|---|---|
| Relative Strength Index (RSI) | 58.46 | 63.58 |
| Support Level | $3.92 | $0.23 |
| Resistance Level | $4.05 | $0.41 |
| Average True Range (ATR) | 0.14 | 0.04 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 71.43 | 67.22 |
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.